Insecticides India Shows Financial Strength Amidst Modest Growth Challenges
Insecticides India, a small-cap agrochemical firm, has recently adjusted its financial evaluation, reflecting strong debt management and a low Debt to EBITDA ratio. The company reported a robust Return on Capital Employed and significant growth in Profit After Tax, alongside a healthy cash position and attractive valuation metrics.
Insecticides India, a small-cap player in the pesticides and agrochemicals sector, has recently undergone an evaluation adjustment reflecting its financial standing. The company has demonstrated a strong capacity to manage its debt, evidenced by a low Debt to EBITDA ratio of 0.79 times. This financial stability is complemented by positive results over the last four consecutive quarters, showcasing a robust Return on Capital Employed (ROCE) of 14.93% and a significant growth in Profit After Tax (PAT) for the latest quarter, reaching Rs 17.37 crore, which marks a 41.1% increase.Additionally, Insecticides India holds a healthy cash position, with cash and cash equivalents at their highest level of Rs 71.57 crore. The company's Return on Equity (ROE) stands at 11.7, indicating an attractive valuation with a Price to Book Value ratio of 1.6. Despite a notable return of 25.22% over the past year, which outpaces the broader market, the company has faced challenges in long-term growth, with net sales and operating profit showing modest annual growth rates of 7.66% and 0.87%, respectively.
For more insights on Insecticides India and its financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
